next-generation sequencing

next-generation sequencing is a term used to describe a suite of technologies, including Illumina sequencing, Roche 454 sequencing, and Life Technologies' Ion Torrent sequencing, that enable the rapid sequencing of large stretches of DNA or RNA. These technologies have revolutionized the field of genomics, allowing researchers to study the human genome, as well as the genomes of other organisms, such as Escherichia coli, Saccharomyces cerevisiae, and Caenorhabditis elegans, in unprecedented detail. The development of next-generation sequencing technologies has been driven by the work of researchers such as David Haussler, Eric Lander, and Francis Collins, who have made significant contributions to the Human Genome Project. Next-generation sequencing has also been influenced by the work of companies such as Illumina, Thermo Fisher Scientific, and Agilent Technologies, which have developed and marketed many of the key technologies used in the field.

Introduction to Next-Generation Sequencing

Next-generation sequencing is a powerful tool for studying the genome and transcriptome of organisms. It has been used to study a wide range of topics, including the genetics of disease, the evolution of species, and the ecology of microbial communities. Researchers such as Craig Venter, George Church, and Jennifer Doudna have used next-generation sequencing to study the genomes of organisms such as Homo sapiens, Mus musculus, and Arabidopsis thaliana. Next-generation sequencing has also been used to study the genomes of ancient DNA samples, such as those from Ötzi the Iceman and King Richard III of England, which has provided insights into the history and migration of human populations. The use of next-generation sequencing has been facilitated by the development of bioinformatics tools, such as BLAST, GenBank, and UCSC Genome Browser, which have been developed by researchers at National Institutes of Health, European Bioinformatics Institute, and University of California, Santa Cruz.

Principles and Methods

The principles of next-generation sequencing involve the use of enzymes such as DNA polymerase and reverse transcriptase to synthesize complementary DNA (cDNA) from RNA or DNA templates. The cDNA is then sequenced using technologies such as pyrosequencing, sequencing by synthesis, or ion semiconductor sequencing, which have been developed by companies such as Roche, Illumina, and Life Technologies. The sequencing data is then analyzed using bioinformatics tools, such as Bowtie, BWA, and SAMtools, which have been developed by researchers at Johns Hopkins University, University of California, Berkeley, and Wellcome Sanger Institute. Next-generation sequencing has been used to study a wide range of organisms, including bacteria such as Escherichia coli and Bacillus subtilis, archaea such as Methanococcus jannaschii, and eukaryotes such as Saccharomyces cerevisiae and Caenorhabditis elegans. Researchers such as David Baltimore, Michael Rosbash, and Allan Spradling have used next-generation sequencing to study the genomes and transcriptomes of these organisms.

Applications of Next-Generation Sequencing

Next-generation sequencing has a wide range of applications, including the study of genetic disease, the development of personalized medicine, and the analysis of microbial communities. Researchers such as Francis Collins, Eric Lander, and David Altshuler have used next-generation sequencing to study the genetics of diseases such as cancer, diabetes, and Alzheimer's disease. Next-generation sequencing has also been used to study the genomes of microorganisms such as influenza virus, HIV, and Ebola virus, which has provided insights into the evolution and transmission of these pathogens. The use of next-generation sequencing has been facilitated by the development of bioinformatics tools, such as GenBank, RefSeq, and UCSC Genome Browser, which have been developed by researchers at National Institutes of Health, National Center for Biotechnology Information, and University of California, Santa Cruz. Companies such as Illumina, Thermo Fisher Scientific, and Agilent Technologies have also developed and marketed many of the key technologies used in the field.

Data Analysis and Interpretation

The analysis and interpretation of next-generation sequencing data is a complex task that requires the use of bioinformatics tools and statistical methods. Researchers such as Gerald Rubin, Bruce Birren, and Chad Nusbaum have developed bioinformatics tools, such as BLAST, GenBank, and UCSC Genome Browser, which are used to analyze and interpret next-generation sequencing data. The data is typically analyzed using pipeline tools, such as Galaxy, Bioconductor, and GenomicRanges, which have been developed by researchers at Pennsylvania State University, Fred Hutchinson Cancer Research Center, and University of California, Berkeley. The results of the analysis are then interpreted in the context of the biological system being studied, using databases such as Gene Ontology, KEGG, and Reactome, which have been developed by researchers at European Bioinformatics Institute, Kyoto University, and Ontario Institute for Cancer Research.

History and Development

The development of next-generation sequencing technologies has a long and complex history, involving the contributions of many researchers and companies. The first next-generation sequencing technology, pyrosequencing, was developed by Mostafa Ronaghi and Pål Nyrén in the 1990s. This was followed by the development of other technologies, such as sequencing by synthesis and ion semiconductor sequencing, which were developed by companies such as Illumina, Roche, and Life Technologies. Researchers such as David Haussler, Eric Lander, and Francis Collins have played a key role in the development of next-generation sequencing technologies, and have used these technologies to study the human genome and the genomes of other organisms. The development of next-generation sequencing has also been influenced by the work of companies such as Agilent Technologies, Thermo Fisher Scientific, and PerkinElmer, which have developed and marketed many of the key technologies used in the field.

Comparison to Traditional Sequencing Techniques

Next-generation sequencing technologies have several advantages over traditional sequencing techniques, such as Sanger sequencing. Next-generation sequencing is much faster and cheaper than traditional sequencing, and can be used to sequence large stretches of DNA or RNA. Researchers such as Craig Venter, George Church, and Jennifer Doudna have used next-generation sequencing to study the genomes of organisms such as Homo sapiens, Mus musculus, and Arabidopsis thaliana. Next-generation sequencing has also been used to study the genomes of ancient DNA samples, such as those from Ötzi the Iceman and King Richard III of England, which has provided insights into the history and migration of human populations. The use of next-generation sequencing has been facilitated by the development of bioinformatics tools, such as BLAST, GenBank, and UCSC Genome Browser, which have been developed by researchers at National Institutes of Health, European Bioinformatics Institute, and University of California, Santa Cruz. Companies such as Illumina, Thermo Fisher Scientific, and Agilent Technologies have also developed and marketed many of the key technologies used in the field. Category:Biotechnology